- Home
- SRFM vs RFL Comparison
SRFM vs RFL Comparison
Compare SRFM & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRFM
- RFL
- Stock Information
- Founded
- SRFM 2011
- RFL 2017
- Country
- SRFM United States
- RFL United States
- Employees
- SRFM N/A
- RFL N/A
- Industry
- SRFM Transportation Services
- RFL Real Estate
- Sector
- SRFM Consumer Discretionary
- RFL Finance
- Exchange
- SRFM Nasdaq
- RFL Nasdaq
- Market Cap
- SRFM 58.2M
- RFL 48.4M
- IPO Year
- SRFM 2023
- RFL N/A
- Fundamental
- Price
- SRFM $3.95
- RFL $1.84
- Analyst Decision
- SRFM Buy
- RFL
- Analyst Count
- SRFM 4
- RFL 0
- Target Price
- SRFM $5.56
- RFL N/A
- AVG Volume (30 Days)
- SRFM 13.7M
- RFL 465.0K
- Earning Date
- SRFM 08-13-2025
- RFL 06-11-2025
- Dividend Yield
- SRFM N/A
- RFL N/A
- EPS Growth
- SRFM N/A
- RFL N/A
- EPS
- SRFM N/A
- RFL N/A
- Revenue
- SRFM $112,307,000.00
- RFL $732,000.00
- Revenue This Year
- SRFM N/A
- RFL N/A
- Revenue Next Year
- SRFM $54.32
- RFL N/A
- P/E Ratio
- SRFM N/A
- RFL N/A
- Revenue Growth
- SRFM 31.17
- RFL 35.56
- 52 Week Low
- SRFM $0.90
- RFL $1.27
- 52 Week High
- SRFM $6.72
- RFL $3.19
- Technical
- Relative Strength Index (RSI)
- SRFM 64.64
- RFL 54.72
- Support Level
- SRFM $3.30
- RFL $1.56
- Resistance Level
- SRFM $4.16
- RFL $2.04
- Average True Range (ATR)
- SRFM 0.79
- RFL 0.16
- MACD
- SRFM 0.17
- RFL -0.00
- Stochastic Oscillator
- SRFM 61.32
- RFL 61.54
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.